The Immunothrombotic Phenotype
JBJS Open Access · 2026-07 · 11 (3)
DOI: 10.2106/jbjs.oa.26.00196 ↗Kurz gefasst
Fachartikel in der Zeitschrift JBJS Open Access, 2026-07. Verfasst von Maria F Canizares und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Boston Children's Hospital, Boston, Massachusetts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Avascular necrosis (AVN) is a devastating complication of pediatric septic arthritis (SA). While traditionally attributed to increased intra-articular pressure, emerging evidence suggests that the host’s systemic response to infection may contribute to ischemic injury. We hypothesized that an immunocoagulopathic phenotype characterized by extreme inflammation and platelet consumption would identify children at the highest risk of developing AVN.
Methods
Following institutional review board approval, children aged younger than 18 years diagnosed with SA between 2010 and 2016 were retrospectively identified from a multicenter database. The primary outcome was the development of AVN. Demographic, clinical, microbiologic, and early laboratory variables were collected. Multivariable logistic regression using Firth's penalized likelihood method was used to account for rare events. Subgroup-level predicted risks of AVN were calculated based on combinations of dichotomized laboratory markers.
Results
Among 616 children with SA, 23 developed AVN (incidence, 3.7%). Patients with AVN demonstrated greater early inflammatory burden, including higher C-reactive protein (CRP) levels, lower platelet counts, and more frequent positive blood and tissue cultures. In multivariable analysis, extreme CRP elevation (>160 mg/L) and relative thrombocytopenia (9.3×10 3 /µL) and erythrocyte sedimentation rate (>60 mm/h) were associated with approximately threefold increased odds. A prediction model using these markers demonstrated excellent discrimination (area under the curve, 0.85), with an estimated AVN risk of 43% in the highest-risk group.
Conclusions
In this multicenter cohort, AVN occurred in 3.7% of children with SA. The development of AVN was strongly associated with an immunocoagulopathic phenotype, defined by extreme inflammation (CRP >160 mg/L) and coagulopathy (relative thrombocytopenia
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Boston Children's Hospital, Boston, Massachusetts.
- Department of Orthopaedic Surgery, University of Colorado School of Medicine, Aurora, Colorado.
- Department of Orthopaedic Surgery, Vanderbilt University Medical Center, Monroe Carell Jr. Children's Hospital, Nashville, Tennessee.
ORCID-Profile: Maria F Canizares, Benjamin J Shore, Julia S Sanders, Patricia E Miller, Jonathan G Schoenecker
Zitieren
APA
Canizares, M. F., Shore, B. J., Sanders, J. S., Miller, P. E., Schoenecker, J. G., & Children’s Orthopaedic Trauma and Infection Consortium for Evidence Based Studies (CORTICES) Study Group (2026). The Immunothrombotic Phenotype. JBJS Open Access, 11(3). https://doi.org/10.2106/jbjs.oa.26.00196
Vancouver
Canizares MF, Shore BJ, Sanders JS, Miller PE, Schoenecker JG, Children’s Orthopaedic Trauma and Infection Consortium for Evidence Based Studies (CORTICES) Study Group. The Immunothrombotic Phenotype. JBJS Open Access. 2026;11(3). doi:10.2106/jbjs.oa.26.00196
BibTeX
@article{Canizares2026,
author = {Canizares, Maria F and Shore, Benjamin J and Sanders, Julia S and Miller, Patricia E and Schoenecker, Jonathan G and Children’s Orthopaedic Trauma and Infection Consortium for Evidence Based Studies (CORTICES) Study Group, Children’s Orthopaedic Trauma and Infection Consortium for Evidence Based Studies (CORTICES) Study Group},
title = {The Immunothrombotic Phenotype},
journal = {JBJS Open Access},
year = {2026},
volume = {11},
number = {3},
doi = {10.2106/jbjs.oa.26.00196}
}
EUVIMED